Financials
- Market Capitalization 2.06 B
- Employee 128
- Founded 2012
- CEO N/A
- Website www.auriniapharma.com
- Headquarter Alberta, Canada
- FIGI BBG000BCRJM5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1961 | ADMA ADMA Biologics Inc - Common Stock | 8.97 USD | -1.21% | -3.34% | +8.60% | -51.93% | 2.08 B USD | ||
| 1963 | MESO Mesoblast Limited - American Depositary Shares | 16.22 USD | +5.05% | +12.64% | +16.77% | +44.95% | 2.08 B USD | ||
| 1966 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 35.54 USD | -3.53% | -5.07% | +3.95% | +15.02% | 2.06 B USD | ||
| 1977 | ANAB AnaptysBio, Inc. - Common Stock | 69.81 USD | +5.15% | +12.18% | +23.25% | +98.32% | 2.03 B USD |
Frequently asked questions about Aurinia Pharmaceuticals Inc - Common Shares
What is the Aurinia Pharmaceuticals Inc - Common Shares stock price today?
The current price of Aurinia Pharmaceuticals Inc - Common Shares (AUPH) is 16.03. Over the past 24 hours, the stock has changed by +1.58%. Follow the AUPH chart for real-time price dynamics.
What is the stock ticker of Aurinia Pharmaceuticals Inc - Common Shares?
Aurinia Pharmaceuticals Inc - Common Shares trades under the ticker AUPH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aurinia Pharmaceuticals Inc - Common Shares stock going up?
AUPH has changed by +3.42% over the last week, +0.63% over the last month, and +34.37% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Aurinia Pharmaceuticals Inc - Common Shares net income for the last quarter?
Aurinia Pharmaceuticals Inc - Common Shares reported net income of 34.35 M for the last quarter. The previous quarter showed 210.79 M, which means net income changed by -83.70%.
How many employees does Aurinia Pharmaceuticals Inc - Common Shares have?
As of the latest available data, Aurinia Pharmaceuticals Inc - Common Shares has 128 employees. Workforce size can provide additional context about the company's scale and operations.
What is Aurinia Pharmaceuticals Inc - Common Shares EBITDA?
Aurinia Pharmaceuticals Inc - Common Shares EBITDA is 46.24 M, and its EBITDA margin is 59.5%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aurinia Pharmaceuticals Inc - Common Shares stock?
You can buy Aurinia Pharmaceuticals Inc - Common Shares (AUPH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aurinia Pharmaceuticals Inc - Common Shares stock?
Investing in Aurinia Pharmaceuticals Inc - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AUPH chart and related analysis on metatrader.com as part of your research.